Business
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions will partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium.
About this update from Sophia Genetics Sa
[{"type":"text","content":"BOSTON and ROLLE, Switzerland, Sept. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions will partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium.","length":406,"tagName":"p"},{"type":"image","alt":"SOPHiA GENETICS Logo (PRNewsfoto/SOPHiA GENETICS)","displaySize":"","headline":null,"caption":"SOPHiA GENETICS Logo (PRNewsfoto/SOPHiA GENETICS)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/7af8bf13f8f939ef861dc0027929881b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/n6kFaeXBXi.jQBj8QTEY9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/7af8bf13f8f939ef861dc0027929881b","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/1673202/SOPHiA_GENETICS_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Jessa Ziekenhuis, one of Belgium's largest healthcare institutions, serves a population of over 530,000 and processes more than 3,000 oncology DNA and RNA samples annually. Through this collaboration, the hospital will adopt SOPHiA DDMâ„¢ across its pathology operations to unify its next-generation sequencing (NGS) workflows under a single platform. This full standardization, covering universal library preparation, unified automated protocols, and a fully integrated workflow, will ensure efficiency, harmonization, and compliance with national ComPerMed guidelines, while enabling more effective use of sequencing resources.","length":631,"tagName":"p"},{"type":"text","content":"The hospital will implement six SOPHiA GENETICS applications tailored to its testing needs in solid tumors, hematologic malignancies, and liquid biopsy analysis, enhancing both clinical decision-making and research capabilities.","length":228,"tagName":"p"},{"type":"text","content":"The SOPHiA GENETICS solution combines a cloud-based platform with embedded automation and advanced analysis tools, fully integrated with Jessa Ziekenhuis's Laboratory Information Management System (LIMS). This ensures seamless data flow, consistency...